In the news ShapeTX in the News Company News Media Mentions Blog Company News See All May 4, 2023 ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond January 5, 2023 ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference September 12, 2022 Shape Therapeutics named one of Fierce Biotech’s “Fierce 15” Companies of 2022 Media Mentions See All 23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022) Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022) Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022) Blog See All Generative AI is creating the next generation of therapies: programmable medicine ShapeTX at ASGCT 2023: Programmable Medicine Takes Center Stage Spotlight Video: Charting New Courses Dispatches from The Atlantic Progress Summit: How mRNA Technology Could Save the World RNA editing: Expanding the potential of RNA therapeutics Spotlight Video: Inspired by Nature
